6-(2-chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid
![6-(2-chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid price.](/CAS/20140525/GIF/CB42134099.gif)
|
- $189 - $752
- Product name: 6-(2-chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid
- CAS: 656817-42-4
- MF: C16H13ClFN3O2
- MW: 333.74
- EINECS:
- MDL Number:MFCD03450690
- Synonyms:6-(2-chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid;Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 6-[(2-chloro-4-fluorophenyl)methyl]-5,7-dimethyl-
3 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerChemenu
- Product numberCM271503
- Product description6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylicacid 97%
- Packaging5g
- Price$711
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11077782
- Product description6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylicacid 97%
- Packaging5g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number037807
- Product description6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo-[1,5-a]pyrimidine-3-carboxylic acid
- Packaging500mg
- Price$189
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM271503 | 6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylicacid 97% | 5g | $711 | 2021-12-16 | Buy |
| Crysdot | CD11077782 | 6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylicacid 97% | 5g | $752 | 2021-12-16 | Buy |
| Matrix Scientific | 037807 | 6-(2-Chloro-4-fluorobenzyl)-5,7-dimethylpyrazolo-[1,5-a]pyrimidine-3-carboxylic acid | 500mg | $189 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|